172 related articles for article (PubMed ID: 1750771)
1. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia.
Ng PC; Brownlee KG; Dear PR
Arch Dis Child; 1991 Oct; 66(10 Spec No):1164-6. PubMed ID: 1750771
[TBL] [Abstract][Full Text] [Related]
2. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia.
Shimizu T; Yamashiro Y; Yabuta K
Arch Dis Child; 1992 Apr; 67(4 Spec No):470-1. PubMed ID: 1497731
[No Abstract] [Full Text] [Related]
3. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia.
Ng PC; Fok TF; So KW; Wong W; Yip PK; Liu K
Pediatr Surg Int; 1997 Feb; 12(2-3):211-2. PubMed ID: 9156866
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous gastroduodenal perforation in patients with cancer receiving chemotherapy and steroids. Report of four cases combining 5-fluorouracil infusion and cisplatin with antiemetics dexamethasone.
Liaw CC; Huang JS; Wang HM; Wang CH
Cancer; 1993 Aug; 72(4):1382-5. PubMed ID: 8339228
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
Williams AF
Arch Dis Child; 1993 Sep; 69(3 Spec No):331. PubMed ID: 8215580
[No Abstract] [Full Text] [Related]
6. Small-bowel perforation in very low birth weight neonates treated with high-dose dexamethasone.
De Laet MH; Dassonville M; Johansson A; Lerminiaux C; Seghers V; Van den Eijnden S; Blum D; Vanderwinden JM
Eur J Pediatr Surg; 2000 Oct; 10(5):323-7. PubMed ID: 11194544
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
Ng PC
Arch Dis Child; 1993 Mar; 68(3 Spec No):330-6. PubMed ID: 8466274
[No Abstract] [Full Text] [Related]
8. Gastrointestinal complications associated with dexamethasone treatment.
Smith H; Sinha S
Arch Dis Child; 1992 May; 67(5):667. PubMed ID: 1599326
[No Abstract] [Full Text] [Related]
9. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone.
Kelly EJ; Chatfield SL; Brownlee KG; Ng PC; Newell SJ; Dear PR; Primrose JN
Arch Dis Child; 1993 Jul; 69(1 Spec No):37-9. PubMed ID: 8346951
[TBL] [Abstract][Full Text] [Related]
10. Acute gastroduodenal perforations associated with use of crack.
Lee HS; LaMaute HR; Pizzi WF; Picard DL; Luks FI
Ann Surg; 1990 Jan; 211(1):15-7. PubMed ID: 2403771
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.
Kari MA; Heinonen K; Ikonen RS; Koivisto M; Raivio KO
Arch Dis Child; 1993 May; 68(5 Spec No):566-9. PubMed ID: 8323356
[TBL] [Abstract][Full Text] [Related]
12. Catabolic effect of dexamethasone in the preterm baby.
Brownlee KG; Ng PC; Henderson MJ; Smith M; Green JH; Dear PR
Arch Dis Child; 1992 Jan; 67(1 Spec No):1-4. PubMed ID: 1482427
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants.
Halliday H
J Pediatr; 2001 Jul; 139(1):163-4. PubMed ID: 11463049
[No Abstract] [Full Text] [Related]
14. Growth hormone does not prevent catabolic side effects of dexamethasone in extremely low birth weight preterm infants with bronchopulmonary dysplasia--a pilot study.
Tonini G; Pahor T; Colonna F; de Vonderweid U
J Pediatr Endocrinol Metab; 1997; 10(3):291-4. PubMed ID: 9388821
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.
Brand PL; van Lingen RA; Brus F; Talsma MD; Elzenga NJ
Acta Paediatr; 1993; 82(6-7):614-7. PubMed ID: 8339005
[TBL] [Abstract][Full Text] [Related]
16. Steroid therapy and duodenal ulcer in infants.
Wolf YG; Reyna T; Schropp KP; Harmel RP
J Pediatr Gastroenterol Nutr; 1991 Feb; 12(2):269-71. PubMed ID: 2051278
[TBL] [Abstract][Full Text] [Related]
17. Gastroduodenal effects of nonsteroidal antiinflammatory drugs.
Kimmey MB
Postgrad Med; 1989 Apr; 85(5):65-70, 73. PubMed ID: 2648379
[No Abstract] [Full Text] [Related]
18. Postnatal glucocorticoids in very preterm infants: "the good, the bad, and the ugly"?
Thébaud B; Lacaze-Masmonteil T; Watterberg K
Pediatrics; 2001 Feb; 107(2):413-5. PubMed ID: 11158479
[No Abstract] [Full Text] [Related]
19. The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: a cautionary note.
Frank L
Pediatrics; 1991 Aug; 88(2):413-6. PubMed ID: 1741827
[No Abstract] [Full Text] [Related]
20. [Dexamethasone therapy in bronchopulmonary dysplasia].
Merz U; Kuehl G; Linderkamp O
Klin Padiatr; 1989; 201(1):11-5. PubMed ID: 2495383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
